F3 Logic, LLC Amgen Inc Transaction History

F3 Logic, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$224.46 - $253.15 $1,571 - $1,772	7 Added 0.19%	3,771 $835,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $868,392 - $966,369	3,764 New	3,764 $916,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $192,469 - $213,531	-824 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $100,969 - $117,663	-455 Reduced 35.57%	824 $205,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $19,906 - $23,705	-92 Reduced 6.71%	1,279 $293,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $6,570 - $7,306	-28 Reduced 2.0%	1,371 $348,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $276,736 - $339,593	1,399 New	1,399 $328,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $443,458 - $531,355	-2,547 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $36,507 - $42,794	-219 Reduced 7.92%	2,547 $472,000
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $270,762 - $305,208	1,497 Added 117.97%	2,766 $525,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $226,389 - $264,269	1,269 New	1,269 $246,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.